Reduction of oxidative stress does not affect recovery of myocardial function: Warm continuous versus cold intermittent blood cardioplegia

被引:12
作者
Biagioli, B
Borrelli, E
Maccherini, M
Bellomo, G
Lisi, G
Giomarelli, P
Sani, G
Toscano, M
机构
[1] UNIV SIENA,IST CHIRURGIA TORAC & CARDIOVASC & TECNOL BIOMED,I-53100 SIENA,ITALY
[2] UNIV TURIN,DIPARTIMENTO MED & ONCOL SPERIMENTALE,TURIN,ITALY
关键词
oxygen free radicals; blood cardioplegia; coronary artery bypass graft;
D O I
10.1136/hrt.77.5.465
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-To compare oxidative stress after cardiac surgery in patients treated with two different methods of myocardial protection: warm continuous versus cold intermittent blood cardioplegia. To correlate oxidative stress with postoperative myocardial dysfunction. Design-Prospective, randomised, double blind, trial. Setting-Institutional centre of cardiovascular surgery. Patients-20 patients were selected for coronary artery bypass surgery (CABG) on the following basis: stable angina, ejection fraction > 50%, double or triple vessel disease, no previous CABG or associated disease. Patients were randomised to two groups of 10 patients each. Interventions-Patients underwent CABG with one of two different methods of myocardial protection and cardiopulmonary bypass. CBC group: intermittent cold blood antegrade-retrograde cardioplegia with moderate hypothermic cardiopulmonary bypass; WBC group: continuous warm blood antegrade-retrograde cardioplegia with mild hypothermic cardiopulmonary bypass. Main outcome measure The index of oxidative stress used was the alteration of blood and plasma glutathione status. Samples were collected from the coronary sinus and peripheral vein before anaesthesia (T1), before aortic unclamping (T2), 15 minutes (T3), and 30 minutes (T4) after unclamping. Haemodynamic parameters were measured with thermodilution techniques. Results-Oxidised glutathione and glutathione-cysteine mixed disulphide significantly increased in the coronary sinus plasma in the CBC group, and the overall redox balance of glutathione was decreased (P < 0.01) at T2-T4 versus T1, and compared with the WBC group. Comparable results were obtained for coronary sinus blood. There was no correlation between postoperative haemodynamic measurements and oxidative stress markers. Conclusions-Oxidative stress was significant in patients undergoing CABG using cold blood cardioplegia, while the warm technique minimised the effects of ischaemia. However, oxidative stress was not correlated with myocardial dysfunction following CABG.
引用
收藏
页码:465 / 473
页数:9
相关论文
共 47 条
  • [11] BUCKBERG GD, 1979, J THORAC CARDIOV SUR, V77, P803
  • [12] CURELLO S, 1986, J APPL CARDIOL, V1, P311
  • [13] DELNIDO PJ, 1987, CIRCULATION, V76, P174
  • [14] CHROMOSOMAL-ABERRATIONS AND NEUTROPHIL ACTIVATION-INDUCED BY REPERFUSION IN THE ISCHEMIC HUMAN HEART
    FABIANI, JN
    FARAH, B
    VUILLEMINOT, A
    LECOMPTE, T
    EMERIT, I
    CHARDIGNY, C
    CARPENTIER, A
    [J]. EUROPEAN HEART JOURNAL, 1993, 14 : 12 - 17
  • [15] OCCURRENCE OF OXIDATIVE STRESS DURING REPERFUSION OF THE HUMAN-HEART
    FERRARI, R
    ALFIERI, O
    CURELLO, S
    CECONI, C
    CARGNONI, A
    MARZOLLO, P
    PARDINI, A
    CARADONNA, E
    VISIOLI, O
    [J]. CIRCULATION, 1990, 81 (01) : 201 - 211
  • [16] OXYGEN RADICALS IN CARDIAC-SURGERY
    GARDNER, TJ
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 1988, 4 (01) : 45 - 50
  • [17] DIRECT DETECTION OF FREE-RADICALS IN THE REPERFUSED RAT-HEART USING ELECTRON-SPIN-RESONANCE SPECTROSCOPY
    GARLICK, PB
    DAVIES, MJ
    HEARSE, DJ
    SLATER, TF
    [J]. CIRCULATION RESEARCH, 1987, 61 (05) : 757 - 760
  • [18] GOLD JP, 1979, SURG FORUM, V30, P252
  • [19] REPERFUSION INDUCED INJURY - MANIFESTATIONS, MECHANISMS, AND CLINICAL RELEVANCE (REPRINTED FROM TRENDS IN CARDIOVASCULAR MEDICINE, VOL 1, PG 233-40, 1991)
    HEARSE, DJ
    BOLLI, R
    [J]. CARDIOVASCULAR RESEARCH, 1992, 26 (02) : 101 - 108
  • [20] REPERFUSION-INDUCED INJURY - A POSSIBLE ROLE FOR OXIDANT STRESS AND ITS MANIPULATION
    HEARSE, DJ
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 1991, 5 : 225 - 235